The American Journal of Medicine
Volume 122, Issue 10, Supplement , Pages S1-S2 , October 2009

Introduction: Recommendations for the Diagnosis, Assessment, and Treatment of Neuropathic Pain

  • Robert H. Dworkin, PhD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Robert H. Dworkin, PhD, University of Rochester Medical Center, 601 Elmwood Avenue, Box 604, Rochester, New York 14642-8604

References 

  1. Treede R-D, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–1635
  2. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350–354
  3. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain. 1999;3:335–342
  4. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237–251
  5. Woolf CJ, Max MB. Mechanism-based pain diagnosis. Anesthesiology. 2001;95:241–249
  6. Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med. 2004;140:441–451
  7. Hansson PT, Dickenson AH. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain. 2005;113:251–254
  8. Kieburtz K, Simpson D, Yiannoutsos C, et al. AIDS Clinical Trial Group 242 Protocol Team A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology. 1998;51:1682–1688
  9. Shlay JC, Chaloner K, Max MB, et al. Terry Beirn Community Programs for Clinical Research on AIDS Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA. 1998;280:1590–1595
  10. In:  Campbell JN,  Basbaum AI,  Dray A,  Dubner R,  Dworkin RH,  Sang CN editor. Emerging Strategies for the Treatment of Neuropathic Pain. Seattle, WA: International Association for the Study of Pain Press; 2006;
  11. Turk DC. Customizing treatment for chronic pain patients: who, what and why?. Clin J Pain. 1990;6:255–270

 Dr. Dworkin has received support from the US National Institutes of Health (NIH) and the US Veterans Administration (VA). He is a Special Government Employee of the US Food and Drug Administration Center for Drug Evaluation and Research (FDA CDER).

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9343(09)00393-3

doi: 10.1016/j.amjmed.2009.04.004

The American Journal of Medicine
Volume 122, Issue 10, Supplement , Pages S1-S2 , October 2009

Article Tools